Cancer Immunology, Immunotherapy Issues Research Articles in November 2023 Edition
October 15, 2023
October 15, 2023
BASEL, Switzerland, Oct. 15 -- Cancer Immunology, Immunotherapy, a peer-reviewed journal that says it advances in the field of tumor immunology, published research articles on the following topics in its November 2023 edition (Vol. 72, Issue 11):
* TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors
* Cancer management during the COVID-19 world pandemic
* Radiation-associated secondary malignancies: a novel opportunity for applyin . . .
* TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors
* Cancer management during the COVID-19 world pandemic
* Radiation-associated secondary malignancies: a novel opportunity for applyin . . .